CBOE vs FGEN · P/E 24, rev $2.72B vs rev $29.6M
Cboe Global Markets Inc (CBOE) versus FibroGen Inc (FGEN) — a side-by-side from cached financials, not a winner call.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Latest reported CBOE revenue for 2026-06-30 was $2.72B. Net income was $738.8M. CBOE currently screens at market cap $29.50B and trailing P/E 24.1.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
CBOE currently screens at market cap $29.50B and trailing P/E 24.1. FGEN currently screens at market cap $39.3M.
Not investment advice. Open the CBOE and FGEN stock pages for the full models.
Not investment advice.